中文别名 |
鲁比替康;9-硝基喜树碱;卢比替康;鲁比特康;9-Nitrocamptothecin 9-硝基喜树碱;9-硝基-20(S)-喜树碱(RG);9-硝基-20-S-喜树碱;鲁比特康Rubitecan;喜树碱;(4S)-4-乙基-4-羟基-10-硝基-1H-吡喃并[3',4':6,7]氮茚并[1,2-b]喹啉-3,14[4H,12H]-二酮;(4S)-4-乙基-4-羟基-10-硝基-1H-吡喃并[3',4':6,7]中氮茚并[1,2-B]喹啉-3,14[4H,12H]-二酮;4-(S)-乙基-4-羟基-10-硝基-1氢-吡喃并[3',4':6,7]氮茚并[1,2,-6]喹啉;4-(S)-乙基-4-羟基-10-硝基-1氢-吡喃并[3’,4’:6,7]氮茚并[1,2,-6]喹啉-3,14(4氢,12氢)-二酮 |
英文别名 |
9-NITROCAMPTOTHECIN;CAMPTOTHECIN, 9-NITRO-20(S)-(RG);Rubitecan;1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLINE-3,14(4H,12H)-DIONE,4-ETHYL-4-HYDROXY-10-NITRO-, (4S)-;9-NITRO-20(S)-CAMPTOTHECIN;9-Nitrocellulose camptothecine;PYRIDOXINE 3,4-DIPALMITATE;(4S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;Orathecin;9-Nitrocellulose camptothecine;Rubitecan;9-NC;Camptogen;RFS 2000;Nitrocamptothecin;H19C446XXB;C20H15N3O6;9NC;Rubitecan [USAN:INN];rubitecanum;rubitecán;rubitécan;UQ0493300;(4s)-4-ethyl-4-hydroxy-10-nitro-1h-pyrano(3',4':6,7)indolizino(1,2-b)QUINOLINE-3,14(4h,12h)-dione;10-Nitro-camptothecin;9-nitro-(20S)-camptothecin;9-nitro-20-(S)-camptothecin;9-Nitrocamptothecin;Rubitecan;Camptogen; Orathecin;https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:90225;rubitecan; rubitecanum;Rubitecan|9-Nitrocamptothecin;ST-2617;UNII:H19C446XXB;UNII-H19C446XXB;(4S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione (ACI);1H-Pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-10-nitro-, (S)- (ZCI);9-Nitro-20(S)-camptothecin;RFS2000;Tox21_112597;RUBITECAN [MART.];NCGC00167969-01;AC-13389;WLZ3809;BDBM50248354;(s)-4-ethyl-4-hydroxy-10-nitro-1h-pyrano[3',4':6,7]-indolizino[1,2-b]quinoline-3,14(4h,12h)-dione;RFS 2000;9-Nitrocamptothecin;Q-100889;Q510113;CHEBI:90225;BCP06207;DB06159;CHEMBL77305;DTXSID7046752;1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-9-nitro-;BRD-K79821389-001-01-9;Rubitecan (USAN/INN);1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-10-nitro-, (4S)-;RUBITECAN [WHO-DD];AS-14856;CAS-91421-42-0;SCHEMBL8640;EX-A4326;Camptothecin, 9-nitro-20(S);CS-0007769;RUBITECAN [MI];AKOS015895332;9-nitro camptothecin;D04031;1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-9-nitro-;AC-33157;(S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;NCGC00167969-03;Rubitecan [USAN];9-NC, 9-Nitro-camptothecin, Partaject Orathecin, Partaject rubitecan, RFS 2000;N0822;s2288;MFCD06656294;ethyl-hydroxy-nitro-[?]dione;VHXNKPBCCMUMSW-FQEVSTJZSA-N;(S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3\\',4\\':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;91421-42-0;RFS-2000;AKOS025149224;(S)-4-ethyl-4-hydroxy-10-nitro-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione;RUBITECAN [INN];BRD-K79821389-001-03-5;NCGC00167969-02;AC-25083;DTXCID5026752;(19S)-19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;HY-13744 |